Can a non-surgical contraceptive work for pets?

1. Immunocontraception: Vaccines that reduce fertility

Immunocontraception uses vaccines to trigger antibodies against key reproductive hormones or proteins, interfering with normal fertility processes.

• Most vaccines target gonadotropin-releasing hormone (GnRH), which controls ovulation.
• Other vaccines target zona pellucida proteins that enable fertilization.
• Some studies explored vaccines aimed at sperm or hormone receptors.

Vaccines such as GonaCon have shown temporary contraceptive effects but inconsistent results.

• GonaCon can produce infertility for about one year in many cats and dogs.
• The USDA originally developed GonaCon for non-lethal wildlife population control.
• Most animals required booster injections to maintain infertility.
• Results varied widely between individuals and studies.
• Some animals never became fully infertile, even after repeated vaccinations.

Researchers also raised concerns about safety and reliability.

• Possible risk of autoimmune reactions.
• Unpredictable duration of infertility.
• No immunocontraceptive vaccine currently provides permanent sterility in cats or dogs.

2. Hormonal methods: Effective but problematic

Hormone-based non-surgical contraceptives are the most extensively studied methods, but they raise major safety concerns.

• Methods include progestins, GnRH agonists, and GnRH antagonists.
• These drugs are delivered as pills, injections, or implants.

Products such as deslorelin implants can temporarily suppress reproduction.

• Implants can delay puberty or suppress estrus for months or years.
• Fertility usually returns after the implant wears off or is removed.

Despite their effectiveness, side effects are common and sometimes severe.

• Reported problems include uterine disease and mammary tumors.
• Other risks include insulin resistance and diabetes.
• Long-term hormone manipulation disrupts metabolic and neurological processes.
• Research on spaying and neutering already shows that hormone changes can affect health.

3. Corpus luteum modulators: A narrower approach

Some studies focused on drugs that disrupt the corpus luteum in female dogs, which produces progesterone needed to maintain pregnancy.

• Drugs studied include trilostane, bromocriptine, and cabergoline.
• These drugs lower progesterone levels.
• Treatments interrupt the estrous cycle without directly targeting the brain.

This approach may reduce some systemic side effects. However, the effects were temporary and did not result in permanent sterility.

4. Kisspeptin-based methods: Promising but uncertain

Kisspeptin is a key signaling molecule that activates a multi-step hormone system regulating fertility. Researchers hope that targeting kisspeptin could suppress reproduction more precisely.

• Studies tested kisspeptin peptides and antagonists in cats and dogs.
• Results varied by dose, timing, and route of administration.

Some findings suggest short-term safety.

• Certain compounds altered hormone levels without obvious immediate harm.
• Researchers have not established safe, reliable protocols for long-term use.

5. Devices, ultrasound, and ovarian injections

The review also examined physical and chemical contraceptive methods that do not rely on hormones.

• Therapeutic ultrasound damaged ovarian tissue.
• Results were inconsistent and caused inflammation.

Mechanical and chemical barriers posed practical challenges.

• Intrauterine devices proved impractical in dogs.
• Placement requires difficult procedures
• Complications remain common.

Some methods contradicted the goal of being non-surgical.

• Zinc gluconate injections damaged the ovaries.
• Delivery required surgery, undermining their usefulness.

6. Gene therapy: The most encouraging results so far

Gene-based non-surgical contraceptives produced some of the most impressive results in the review.

• Scientists used harmless viruses to deliver genes that stop the ovaries from releasing eggs.

One study showed particularly striking results.

• Treated female cats became completely infertile after a single treatment.
• The introduced gene increased production of a hormone that prevents ovulation.
• Without ovulation, pregnancy cannot occur.

Despite this promise, major hurdles remain.

• Gene therapy is still experimental.
• Long-term safety data are limited.
• Regulatory approval is still far away.